Feed aggregator

How ChatGPT Can–and Can't–Help Your Job Search

Biospace news - Sun, 09/03/2023 - 02:00
How ChatGPT Can–and Can't–Help Your Job Search 3/9/2023

QurAlis’ Biomarker-Driven Approach Attracts $88M in Series B

Biospace news - Sun, 09/03/2023 - 02:00
QurAlis’ Biomarker-Driven Approach Attracts $88M in Series B 3/9/2023

Lilly’s Alzheimer’s Struggles Continue as Preclinical Disease Asset Fails Phase III

Biospace news - Sun, 09/03/2023 - 02:00
Lilly’s Alzheimer’s Struggles Continue as Preclinical Disease Asset Fails Phase III 3/9/2023

Closing the Opportunity Gap: How Inceptor Bio Supports Women Leaders

Biospace news - Sun, 09/03/2023 - 02:00
Closing the Opportunity Gap: How Inceptor Bio Supports Women Leaders 3/9/2023

Boehringer Ingelheim to Mine Ginkgo’s Molecules in $406M Undruggable Targets ...

Biospace news - Sat, 08/05/2023 - 02:00
Boehringer Ingelheim to Mine Ginkgo’s Molecules in $406M Undruggable Targets ... 5/8/2023

BioNTech Looks to Expand into Other Markets as COVID-19 Revenues Dwindle

Biospace news - Sat, 08/05/2023 - 02:00
BioNTech Looks to Expand into Other Markets as COVID-19 Revenues Dwindle 5/8/2023

BMS Cuts Jobs in New Jersey, Cites ‘Constantly Evolving’ Business Model

Biospace news - Sat, 08/05/2023 - 02:00
BMS Cuts Jobs in New Jersey, Cites ‘Constantly Evolving’ Business Model 5/8/2023

Biopharma Bets Big on Antibody-Drug Conjugates

Biospace news - Sat, 08/05/2023 - 02:00
Biopharma Bets Big on Antibody-Drug Conjugates 5/8/2023

Opinion: Hope on the Horizon for Sjogren’s Syndrome

Biospace news - Sat, 08/05/2023 - 02:00
Opinion: Hope on the Horizon for Sjogren’s Syndrome 5/8/2023

FDA Action Alert: Sarepta, Protalix, Otsuka/Lundbeck and More

Biospace news - Sat, 08/05/2023 - 02:00
FDA Action Alert: Sarepta, Protalix, Otsuka/Lundbeck and More 5/8/2023

FDA Guidance May Bolster Confidence in Decentralized Clinical Trials

Biospace news - Sat, 08/05/2023 - 02:00
FDA Guidance May Bolster Confidence in Decentralized Clinical Trials 5/8/2023

In Tough Market, CODA Quietly Shuts Doors

Biospace news - Thu, 08/03/2023 - 02:00
In Tough Market, CODA Quietly Shuts Doors 3/8/2023

BioMarin Answers BridgeBio's Challenge with sNDA for Achondroplasia

Biospace news - Thu, 08/03/2023 - 02:00
BioMarin Answers BridgeBio's Challenge with sNDA for Achondroplasia 3/8/2023

FDA Accepts Mesoblast’s Ryoncil Resubmission for Pediatric GVHD

Biospace news - Thu, 08/03/2023 - 02:00
FDA Accepts Mesoblast’s Ryoncil Resubmission for Pediatric GVHD 3/8/2023

Co-working could Drive Innovation, Distribution of Talent Across U.S.

Biospace news - Thu, 08/03/2023 - 02:00
Co-working could Drive Innovation, Distribution of Talent Across U.S. 3/8/2023

The Decade of RNA Delivery – Beyond the Liver

Biospace news - Thu, 08/03/2023 - 02:00
The Decade of RNA Delivery – Beyond the Liver 3/8/2023

Makena Saga Concludes as FDA Withdraws Approval for Only Preterm Birth Drug on Market

Biospace news - Tue, 07/04/2023 - 02:00
Makena Saga Concludes as FDA Withdraws Approval for Only Preterm Birth Drug on Market 4/7/2023

Novavax Presents COVID-19 Booster and Flu Combo Vaccine Studies

Biospace news - Tue, 07/04/2023 - 02:00
Novavax Presents COVID-19 Booster and Flu Combo Vaccine Studies 4/7/2023

World Vaccine Congress Panel Highlights Exigency of AMR Global Health Crisis

Biospace news - Tue, 07/04/2023 - 02:00
World Vaccine Congress Panel Highlights Exigency of AMR Global Health Crisis 4/7/2023

Merck/Eisai Drops Melanoma Program for Keytruda-Lenvima Combo After Phase III Fail

Biospace news - Tue, 07/04/2023 - 02:00
Merck/Eisai Drops Melanoma Program for Keytruda-Lenvima Combo After Phase III Fail 4/7/2023